Applied BioMath Assess™ Model Libraries

Biotherapeutic Model Pack

Applied BioMath Assess includes 18 models covering 9 common pharmacologies (listed below). Each pharmacology has a 1-compartment model version and a 4-compartment model version. The 4-compartment models can easily be converted to a 3- or 2-compartment models by zeroing out distribution rates.

  • Monospecific Anti-Ligand
    • Bivalent antibody binding to soluble ligand
  • Monospecific Anti-Receptor
    • Bivalent antibody binding to membrane receptor
  • Bispecific Anti-Ligand x Anti-Ligand
    • Bivalent antibody binding to two different soluble ligands
  • Bispecific Anti-Ligand x Anti-Receptor
    • Bivalent antibody binding to soluble ligand and membrane receptor
  • Bispecific Anti-Receptor x Anti-Receptor
    • Bivalent antibody binding to two different membrane receptors
  • Bispecific Anti-Receptor x Anti-Ligand with Membrane Ligand x Receptor Competitor
    • Bivalent antibody binding to soluble ligand and membrane receptor with a membrane receptor and membrane ligand competitor
  • Bispecific Anti-Receptor x Anti-Receptor with Membrane Ligand x Soluble Ligand Competitor
    • Bivalent antibody binding to two different membrane receptors with one membrane ligand and one soluble ligand competitor
  • Bispecific Anti-Receptor x Anti-Receptor with Membrane Ligand x Membrane Ligand Competitor
    • Bivalent antibody binding to two different membrane receptors with two membrane ligand competitors
  • Monospecific Anti-Receptor with Membrane Ligand Competitor
    • Bivalent antibody binding to membrane receptor and membrane ligand competitor

Learn more about the Biotherapeutic Model Pack 

Cell Engager Model Pack

(this requires the purchase of the biotherapeutic model pack)

  • Cell Engager for Solid Tumors
  • Tumor Cell Engager for In-vitro Experiments
  • Effector Cell Engager for Solid Tumors with 2 Cell Types

Learn more about the Cell Engager Model Pack

Avidity Model Pack

(this requires the purchase of the biotherapeutic model pack)

  • Monospecific Anti-Receptor with Avidity (4-Compartment)
  • Bispecific Anti-Ligand x Anti-Receptor with Avidity (4-Compartment)
  • Bispecific Anti-Receptor x Anti-Receptor with Avidity (4-Compartment)
  • Bispecific Anti-Receptor x Anti-Ligand with Membrane Ligand x Receptor Competitor with Avidity (4-Compartment)
  • Bispecific Anti-Receptor x Anti-Receptor with Membrane Ligand x Soluble Ligand Competitor with Avidity (4-Compartment)
  • Bispecific Anti-Receptor x Anti-Receptor with Membrane Ligand x Membrane Ligand Competitor with Avidity (4-Compartment)
  • Monospecific Anti-Receptor with Membrane Ligand Competitor with Avidity (4-Compartment)

Learn more about the Avidity Model Pack

Gene Therapy Model Pack

  • LNP-encapsulated mRNA expressing an intracellular protein in vitro
    • Two-compartment model of mRNA uptake, protein expression, and protein-mediated enzymatic reaction in vitro
  • LNP-encapsulated mRNA expressing an intracellular protein in vivo
    • Two-compartment model of mRNA delivery, protein expression, and protein-mediated enzymatic reaction in vivo
  • LNP-encapsulated mRNA expressing an extracellular protein in vitro
    • Two-compartment model of mRNA delivery, protein expression, and protein-mediated enzymatic reaction in vitro
  • LNP-encapsulated mRNA expressing an extracellular protein in vivo
    • Two-compartment model of mRNA delivery, protein expression, and protein-mediated enzymatic reaction in vivo
  • LNP- encapsulated siRNA expressing an intracellular protein in vitro
  • LNP-encapsulated siRNA expressing an intracellular protein in vivo
  • LNP-encapsulated siRNA expressing an extracellular protein in vitro
  • LNP-encapsulated siRNA expressing an extracellular protein in vivo

Learn more about the Gene Therapy Model Pack

Protein Degrader Model Pack

  • PROTAC degrading an intracellular protein in vitro
    • An in vitro model of a PROTAC targeting and degrading intracellular proteins
  • MGD degrading an intracellular protein in vitro
    • An in vitro model of a molecular glue degrader targeting and degrading intracellular proteins
  • PROTAC degrading an intracellular protein in vivo
    • An in vivo model of a PROTAC targeting and degrading intracellular proteins
  • MGD degrading an intracellular protein in vivo
    • An in vivo model of a molecular glue degrader targeting and degrading intracellular proteins

Learn more about the Protein Degrader Model Pack

Looking for something different?

Don't see your model type? No worries! Our team of modelers will work with you to customize/modify a model that will work best for your project. Feel free to reach out and one of our representatives will get back to you soon.

Contact Us